Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,788 | -16,868 | -7,886 | -14,859 | -9,456 |
| Depreciation Amortization | 483 | 321 | 162 | 271 | 125 |
| Accounts payable and accrued liabilities | 1,114 | 1,722 | 501 | N/A | 505 |
| Other Working Capital | 1,007 | 1,640 | 372 | 1,405 | 176 |
| Other Operating Activity | 1,712 | -1,401 | -437 | 1,349 | 830 |
| Operating Cash Flow | $-26,472 | $-14,586 | $-7,288 | $-11,834 | $-7,820 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -438 | -282 | -211 | -1,647 | -910 |
| Investing Cash Flow | $-438 | $-282 | $-211 | $-1,647 | $-910 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,936 | 9,936 | 9,936 | N/A | N/A |
| Common Stock Issued | 247,478 | 0 | N/A | N/A | N/A |
| Other Financing Activity | 134,470 | 1,972 | 1,972 | 19,989 | 19,989 |
| Financing Cash Flow | $391,884 | $11,908 | $11,908 | $19,989 | $19,989 |
| Beginning Cash Position | 14,632 | 14,632 | 14,632 | 8,124 | 6,508 |
| End Cash Position | 379,606 | 11,672 | 19,041 | 14,632 | 17,767 |
| Net Cash Flow | $364,974 | $-2,960 | $4,409 | $6,508 | $11,259 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,472 | -14,586 | -7,288 | -11,834 | -7,820 |
| Capital Expenditure | -438 | -282 | -211 | N/A | -910 |
| Free Cash Flow | -26,910 | -14,868 | -7,499 | -11,834 | -8,730 |